Tuesday, December 31, 2024 4:49:49 PM
One thing I know about the way the screening hold was handled is that there are marked differences in US and German law regarding human trials/experimentation. I think the FDA had to figure out a way to oblige the Germans with keeping out the last 17 SOC/placebo patients so the hold needed to continue until NWBO no longer would want to enroll the remaining patients which is when the hold was lifted.
I remember discussions on the board about a possible rift with FDA and I believe sentiment_stocks dug into the changes at the top around that time too. The head of the DSMB also blasted a certain biotech reporter for drawing negative conclusions about the L trial that he circulated through his media channels when the screening hold was announced which is even more historical evidence of what was going on then as well as today.
One other thing that was happening is that FDA guidance was in the process of change and there may have been a certain slowness about getting that started. I believe this also ties in to the whole May 10th debacle as the process for changing endpoints and tying into the exceptions for adequate and well controlled studies is quite a dance and includes the risk associated with updating the clinicaltrials site without a presentation to peers about the methods used ie May 10th, 2022 which the manipulators were all too willing to take advantage of believing they could get away with it. By the way, did you notice how quickly that site got updated after the presentation? That was not an oversight by NWBO, that was part of “the process”. I lament getting excited about the good news to be shared on that May 10th and forgetting about the risk to investors created by what the perps could and then did do back then. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
